Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft as Measured by In-Vivo Confocal Microscopy

NCT02308501 is registered in ClinicalTrials.gov with ORA, Inc. as lead sponsor.

NCT NCT02308501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02308501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft as Measured by In-Vivo Confocal Microscopy
Lead sponsor
ORA, Inc.
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2014
Completion date
February 28, 2015
Enrollment
25 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

allergic conjunctivitis